These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18827812)

  • 1. Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels.
    Jesser C; Mucci L; Farmer D; Moon C; Li H; Gaziano JM; Stampfer M; Ma J; Kantoff P
    Br J Cancer; 2008 Nov; 99(10):1743-7. PubMed ID: 18827812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
    Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A G/A polymorphism in the androgen response element 1 of prostate-specific antigen gene correlates with the response to androgen deprivation therapy in Japanese population.
    Shibahara T; Onishi T; Franco OE; Arima K; Nishikawa K; Yanagawa M; Hioki T; Watanabe M; Hirokawa Y; Shiraishi T; Sugimura Y
    Anticancer Res; 2006; 26(5A):3365-71. PubMed ID: 17094454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphic forms of prostate specific antigen and their interaction with androgen receptor trinucleotide repeats in prostate cancer.
    Binnie MC; Alexander FE; Heald C; Habib FK
    Prostate; 2005 Jun; 63(4):309-15. PubMed ID: 15599941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Susceptibility to Prostate Cancer: Prostate-specific Antigen and its Interaction with the Androgen Receptor (United States).
    Sieh W; Edwards KL; Fitzpatrick AL; Srinouanprachanh SL; Farin FM; Monks SA; Kronmal RA; Eaton DL
    Cancer Causes Control; 2006 Mar; 17(2):187-97. PubMed ID: 16425097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Susceptibility to prostate cancer: interaction between genotypes at the androgen receptor and prostate-specific antigen loci.
    Xue W; Irvine RA; Yu MC; Ross RK; Coetzee GA; Ingles SA
    Cancer Res; 2000 Feb; 60(4):839-41. PubMed ID: 10706090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association studies of serum prostate-specific antigen levels and the genetic polymorphisms at the androgen receptor and prostate-specific antigen genes.
    Xu J; Meyers DA; Sterling DA; Zheng SL; Catalona WJ; Cramer SD; Bleecker ER; Ohar J
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):664-9. PubMed ID: 12101115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.
    Lai J; Kedda MA; Hinze K; Smith RL; Yaxley J; Spurdle AB; Morris CP; Harris J; Clements JA
    Carcinogenesis; 2007 May; 28(5):1032-9. PubMed ID: 17151093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSA and androgen-related gene (AR, CYP17, and CYP19) polymorphisms and the risk of adenocarcinoma at prostate biopsy.
    dos Santos RM; de Jesus CM; Trindade Filho JC; Trindade JC; de Camargo JL; Rainho CA; Rogatto SR
    DNA Cell Biol; 2008 Sep; 27(9):497-503. PubMed ID: 18491956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linkage between polymorphisms in the prostate specific antigen ARE1 gene region, prostate cancer risk, and circulating tumor cells.
    Medeiros R; Morais A; Vasconcelos A; Costa S; Pinto D; Oliveira J; Carvalho R; Lopes C
    Prostate; 2002 Sep; 53(1):88-94. PubMed ID: 12210484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic determinants of serum prostate-specific antigen levels in healthy men from a multiethnic cohort.
    Xue WM; Coetzee GA; Ross RK; Irvine R; Kolonel L; Henderson BE; Ingles SA
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):575-9. PubMed ID: 11401905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk.
    Gsur A; Preyer M; Haidinger G; Zidek T; Madersbacher S; Schatzl G; Marberger M; Vutuc C; Micksche M
    Carcinogenesis; 2002 Oct; 23(10):1647-51. PubMed ID: 12376473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of androgen receptor, prostate-specific antigen, and CYP19 gene polymorphisms with prostate carcinoma and benign prostatic hyperplasia in a north Indian population.
    Soni A; Bansal A; Mishra AK; Batra J; Singh LC; Chakraborty A; Yadav DS; Mohanty NK; Saxena S
    Genet Test Mol Biomarkers; 2012 Aug; 16(8):835-40. PubMed ID: 22731640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of allelic variability in prostate specific antigen (PSA) & androgen receptor (AR) genes to serum PSA levels in men with prostate cancer.
    Chavan SV; Maitra A; Roy N; Chavan PR
    Indian J Med Res; 2014 Mar; 139(3):371-8. PubMed ID: 24820830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there an inter-relationship between prostate specific antigen, kallikrein-2 and androgen receptor gene polymorphisms with risk of prostate cancer in north Indian population?
    Mittal RD; Mishra DK; Thangaraj K; Singh R; Mandhani A
    Steroids; 2007 Apr; 72(4):335-41. PubMed ID: 17257635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of genetic variation rs266882 to prostate-specific antigen levels in healthy controls with serum PSA below 2.0 ng/ml.
    Song J; Park H; Lee G
    Biochem Genet; 2013 Apr; 51(3-4):264-74. PubMed ID: 23315126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Androgen receptor gene polymorphism and prostate cancer in Taiwan.
    Huang SP; Chou YH; Chang WS; Wu MT; Yu CC; Wu T; Lee YH; Huang JK; Wu WJ; Huang CH
    J Formos Med Assoc; 2003 Oct; 102(10):680-6. PubMed ID: 14691592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of G/A polymorphism in the androgen response element I of the PSA gene and its interactions with the androgen receptor polymorphisms.
    Rao A; Chang BL; Hawkins G; Hu JJ; Rosser CJ; Hall MC; Meyers DA; Xu J; Cramer SD
    Urology; 2003 Apr; 61(4):864-9. PubMed ID: 12670590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case-control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects.
    Beilin J; Harewood L; Frydenberg M; Mameghan H; Martyres RF; Farish SJ; Yue C; Deam DR; Byron KA; Zajac JD
    Cancer; 2001 Aug; 92(4):941-9. PubMed ID: 11550169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.